Moderna, Inc. Common Stock vs. Sana Biotechnology, Inc. Common Stock
MRNA
Moderna, Inc. Common Stock
$143.97 +5.38%
VS SANASana Biotechnology, Inc. Common Stock
$3.13 +1.29%
Moderna, Inc. Common Stock (MRNA) comes out ahead, leading on 4 of 6 compared factors.
Size & Scale
| MRNA | SANA | |
|---|---|---|
| Market Cap | $54.54 billion | $925.02 million |
| Revenue (TTM) | $2.23 billion | — |
| Net Income (TTM) | $-3,151,000,000 | $-211,822,000 |
MRNA leads on 2 of 3 size & scale factors.
Valuation
| MRNA | SANA | |
|---|---|---|
| Price / Book | 8.07 | 5.98 |
| Price / Sales | 24.48 | — |
SANA leads on 1 of 1 valuation factors.
Profitability
| MRNA | SANA | |
|---|---|---|
| Net Margin | -141.43% | — |
| Return on Equity | -46.61% | -137.04% |
MRNA leads on 1 of 1 profitability factors.
Risk & Sentiment
| MRNA | SANA | |
|---|---|---|
| Short Interest | 0.01% | 0.18% |
MRNA leads on 1 of 1 risk & sentiment factors.
Dig deeper: MRNA overview, MRNA financials, SANA overview, SANA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.